×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share

In the frame of our collaboration with CTO Summit Brazil, we will be streaming in live from Kantonsspital St Gallen (Switzerland) 2 CTO Cases performed by Dr Yamane and Dr Weilenmann.

Live Case n°1: Calcified CTO in tortuous RCA
  • Patient: Male 63 years old
  • Angina CCS II and dyspnea NYHA II
  • Treadmill test with angina but normal ECG
  • Peripheral arterial disease Fontaine IIb
  • CVRF: former smoker (80py), hypertension, dyslipidemia, IDDM
  • Echo: LVEF 69%, inferobasal hypokinesia, no valvular disease
  • Renal function: eGFR =>90 ml/min/1.73m2
  • CAG 25.8.17: severe LAD stenosis, CX without relevant stenosis; short, but calcified CTO of tortuous RCA
  • 25.8.17 PCI of LAD with DES
  • CAG 25.8.17: severe LAD stenosis, CX without relevant stenosis; short, but calcified CTO of tortuous RCA
  • C-CTO score 2
Live Case n°2: CTO of dominant CX
  • Patient: Male 63 years old
  • History of silent inferior myocardial infarction
  • No angina, dyspnea NYHA II
  • Treadmill test: no angina but limiting dyspnea, ST segment normal
  • CVRF: former smoker, arterial hypertension, dyslipidemia
  • Echo: reduced LVEF (50%), inferior hypokinesia, no valvular disease
  • Admitted for CAG on 14.8.17: RIVA and RCA without relevant stenosis, Chronic occlusion of the dominant mid CX
  • CTO of dominant CX
  • J-CTO score: 2

In collaboration with CTO Summit Brazil

Shooting date : 2017-09-15
Last update : 2017-09-18
3 comments
Join the Discussion
  • Zambonialbe A. A very good job!

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Daniel W. Dear Dr. Zambonialbe. Thank you very much. This was a great event. The Brazilian interventionalists also loved it!

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Valery V. Great cases. Thank you very much!

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        Suggestions

        Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
        Honolulu : Wednesday, May 22nd 2024 from 03am to 04am (GMT+2)
        San Francisco : Wednesday, May 22nd 2024 from 06am to 07am (GMT+2)
        New York : Wednesday, May 22nd 2024 from 09am to 10am (GMT+2)
        Buenos Aires : Wednesday, May 22nd 2024 from 10am to 11am (GMT+2)
        Reykjavik : Wednesday, May 22nd 2024 from 01pm to 02pm (GMT+2)
        London / Dublin : Wednesday, May 22nd 2024 from 02pm to 03pm (GMT+2)
        Paris / Berlin : Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
        Istanbul : Wednesday, May 22nd 2024 from 04pm to 05pm (GMT+2)
        Moscou / Dubaï : Wednesday, May 22nd 2024 from 05pm to 06pm (GMT+2)
        Bangkok : Wednesday, May 22nd 2024 from 08pm to 09pm (GMT+2)
        Shanghai : Wednesday, May 22nd 2024 from 09pm to 10pm (GMT+2)
        Tokyo : Wednesday, May 22nd 2024 from 10pm to 11pm (GMT+2)
        Sydney : Thursday, May 23rd 2024 from 12am to 01am (GMT+2)
        Wellington : Thursday, May 23rd 2024 from 02am to 03am (GMT+2)

        DanGER shock trial results and the significance to reduce adverse events

        Share
        Wednesday, September 18th 2024 from 12pm to 01pm (GMT+2)
        Honolulu : Wednesday, September 18th 2024 from 12am to 01am (GMT+2)
        San Francisco : Wednesday, September 18th 2024 from 03am to 04am (GMT+2)
        New York : Wednesday, September 18th 2024 from 06am to 07am (GMT+2)
        Buenos Aires : Wednesday, September 18th 2024 from 07am to 08am (GMT+2)
        Reykjavik : Wednesday, September 18th 2024 from 10am to 11am (GMT+2)
        London / Dublin : Wednesday, September 18th 2024 from 11am to 12pm (GMT+2)
        Paris / Berlin : Wednesday, September 18th 2024 from 12pm to 01pm (GMT+2)
        Istanbul : Wednesday, September 18th 2024 from 01pm to 02pm (GMT+2)
        Moscou / Dubaï : Wednesday, September 18th 2024 from 02pm to 03pm (GMT+2)
        Bangkok : Wednesday, September 18th 2024 from 05pm to 06pm (GMT+2)
        Shanghai : Wednesday, September 18th 2024 from 06pm to 07pm (GMT+2)
        Tokyo : Wednesday, September 18th 2024 from 07pm to 08pm (GMT+2)
        Sydney : Wednesday, September 18th 2024 from 09pm to 10pm (GMT+2)
        Wellington : Wednesday, September 18th 2024 from 11pm to 12am (GMT+2)

        Can PCI outcomes get any better?

        Advancing the standard of care with bioadaptor

        Share
        Friday, May 29th 2026 from 05:30pm to 06:15pm (GMT+2)
        Honolulu : Friday, May 29th 2026 from 05:30am to 06:15am (GMT+2)
        San Francisco : Friday, May 29th 2026 from 08:30am to 09:15am (GMT+2)
        New York : Friday, May 29th 2026 from 11:30am to 12:15pm (GMT+2)
        Buenos Aires : Friday, May 29th 2026 from 12:30pm to 01:15pm (GMT+2)
        Reykjavik : Friday, May 29th 2026 from 03:30pm to 04:15pm (GMT+2)
        London / Dublin : Friday, May 29th 2026 from 04:30pm to 05:15pm (GMT+2)
        Paris / Berlin : Friday, May 29th 2026 from 05:30pm to 06:15pm (GMT+2)
        Istanbul : Friday, May 29th 2026 from 06:30pm to 07:15pm (GMT+2)
        Moscou / Dubaï : Friday, May 29th 2026 from 07:30pm to 08:15pm (GMT+2)
        Bangkok : Friday, May 29th 2026 from 10:30pm to 11:15pm (GMT+2)
        Shanghai : Friday, May 29th 2026 from 11:30pm to 12:15am (GMT+2)
        Tokyo : Saturday, May 30th 2026 from 12:30am to 01:15am (GMT+2)
        Sydney : Saturday, May 30th 2026 from 02:30am to 03:15am (GMT+2)
        Wellington : Saturday, May 30th 2026 from 04:30am to 05:15am (GMT+2)

        Déremboursement en France : évolutions médico‑économiques

        Share
        Friday, October 20th 2023 from 05pm to 07:15pm (GMT+2)
        Honolulu : Friday, October 20th 2023 from 05am to 07:15am (GMT+2)
        San Francisco : Friday, October 20th 2023 from 08am to 10:15am (GMT+2)
        New York : Friday, October 20th 2023 from 11am to 01:15pm (GMT+2)
        Buenos Aires : Friday, October 20th 2023 from 12pm to 02:15pm (GMT+2)
        Reykjavik : Friday, October 20th 2023 from 03pm to 05:15pm (GMT+2)
        London / Dublin : Friday, October 20th 2023 from 04pm to 06:15pm (GMT+2)
        Paris / Berlin : Friday, October 20th 2023 from 05pm to 07:15pm (GMT+2)
        Istanbul : Friday, October 20th 2023 from 06pm to 08:15pm (GMT+2)
        Moscou / Dubaï : Friday, October 20th 2023 from 07pm to 09:15pm (GMT+2)
        Bangkok : Friday, October 20th 2023 from 10pm to 12:15am (GMT+2)
        Shanghai : Friday, October 20th 2023 from 11pm to 01:15am (GMT+2)
        Tokyo : Saturday, October 21st 2023 from 12am to 02:15am (GMT+2)
        Sydney : Saturday, October 21st 2023 from 02am to 04:15am (GMT+2)
        Wellington : Saturday, October 21st 2023 from 04am to 06:15am (GMT+2)

        Bifurcation PCI: an immersive experience

        Live cases from the Visible Heart® Lab

        Share
        Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
        Honolulu : Monday, October 30th 2023 from 05am to 06am (GMT+1)
        San Francisco : Monday, October 30th 2023 from 07am to 08am (GMT+1)
        New York : Monday, October 30th 2023 from 10am to 11am (GMT+1)
        Buenos Aires : Monday, October 30th 2023 from 12pm to 01pm (GMT+1)
        London / Dublin : Monday, October 30th 2023 from 03pm to 04pm (GMT+1)
        Paris / Berlin : Monday, October 30th 2023 from 04pm to 05pm (GMT+1)
        Istanbul : Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
        Moscou / Dubaï : Monday, October 30th 2023 from 07pm to 08pm (GMT+1)
        Bangkok : Monday, October 30th 2023 from 10pm to 11pm (GMT+1)
        Shanghai : Monday, October 30th 2023 from 11pm to 12am (GMT+1)
        Tokyo : Tuesday, October 31st 2023 from 12am to 01am (GMT+1)
        Sydney : Tuesday, October 31st 2023 from 01am to 02am (GMT+1)
        Wellington : Tuesday, October 31st 2023 from 03am to 04am (GMT+1)

        How do the new antithrombotic recommendations affect your HBR patients?

        Gain insights from a patient case analysis

        Share
        Wednesday, June 21st 2023 from 04pm to 05:30pm (GMT+2)
        Honolulu : Wednesday, June 21st 2023 from 04am to 05:30am (GMT+2)
        San Francisco : Wednesday, June 21st 2023 from 07am to 08:30am (GMT+2)
        New York : Wednesday, June 21st 2023 from 10am to 11:30am (GMT+2)
        Buenos Aires : Wednesday, June 21st 2023 from 11am to 12:30pm (GMT+2)
        Reykjavik : Wednesday, June 21st 2023 from 02pm to 03:30pm (GMT+2)
        London / Dublin : Wednesday, June 21st 2023 from 03pm to 04:30pm (GMT+2)
        Paris / Berlin : Wednesday, June 21st 2023 from 04pm to 05:30pm (GMT+2)
        Istanbul : Wednesday, June 21st 2023 from 05pm to 06:30pm (GMT+2)
        Moscou / Dubaï : Wednesday, June 21st 2023 from 06pm to 07:30pm (GMT+2)
        Bangkok : Wednesday, June 21st 2023 from 09pm to 10:30pm (GMT+2)
        Shanghai : Wednesday, June 21st 2023 from 10pm to 11:30pm (GMT+2)
        Tokyo : Wednesday, June 21st 2023 from 11pm to 12:30am (GMT+2)
        Sydney : Thursday, June 22nd 2023 from 01am to 02:30am (GMT+2)
        Wellington : Thursday, June 22nd 2023 from 03am to 04:30am (GMT+2)

        Strategies and techniques to treat multivessel disease with complex lesions

        Share
        Scroll Up